BLISOVI Drug Patent Profile
✉ Email this page to a colleague
When do Blisovi patents expire, and what generic alternatives are available?
Blisovi is a drug marketed by Lupin and is included in three NDAs.
The generic ingredient in BLISOVI is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BLISOVI?
- What are the global sales for BLISOVI?
- What is Average Wholesale Price for BLISOVI?
Summary for BLISOVI
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Drug Prices: | Drug price information for BLISOVI |
| Drug Sales Revenues: | Drug sales revenues for BLISOVI |
| DailyMed Link: | BLISOVI at DailyMed |
US Patents and Regulatory Information for BLISOVI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | BLISOVI 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 091398-001 | Oct 28, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Lupin | BLISOVI FE 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 201585-001 | Nov 18, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Lupin | BLISOVI FE 1/20 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 201584-001 | Nov 18, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
